Case study: Demonstrating strength of RWE in regulatory submission

With increased focus on making oncology clinical trials more representative of real-world populations, a top life sciences company used Flatiron’s RWE solutions to understand the impact of practice-level variables, such as rural/urban location, Medicaid percentage, and patient-physician ratio, on treatment outcomes.

Download this case study to see how Flatiron’s real-world evidence offered valuable insights on confounding bias to support regulatory decision-making.